A case-control study of risk factors for HIV-negative children with cryptococcal meningitis in Shi Jiazhuang, China

BMC Infectious Diseases

Volumn 12, Issue , 2012, Pages

  Guo, Jianhua ^a   Zhou, Jikun ^a   Zhang, Shiyong ^a   Zhang, Xin ^b   Li, Jing ^a   Sun, Yinqi ^a   Qi, Shunxiang ^a  

^a Shi Jiazhuang Center for Disease Prevention and Control (CDC)   (China)

^b Hebei Provincial children's hospital   (China)

Author keywords

Bird droppings and sacrophytes; Children; Clinical features; Cryptococcal meningitis; Cryptococcosis; Epidemiologic characteristics; Risk factors

Indexed keywords

GLUCOSE;

ADOLESCENT; ARTICLE; CASE CONTROL STUDY; CHILD; CHINA; CLINICAL ARTICLE; CRYPTOCOCCAL MENINGITIS; CRYPTOCOCCUS NEOFORMANS; EPIDEMIOLOGICAL DATA; FATALITY; FEMALE; HEADACHE; HUMAN; INFANT; INTRACRANIAL PRESSURE; LEUKOCYTOSIS; MALE; MENTAL HEALTH; MORBIDITY; NAUSEA; PLEOCYTOSIS; PRESCHOOL CHILD; PROTEIN CEREBROSPINAL FLUID LEVEL; RISK FACTOR; RURAL AREA; SCHOOL CHILD; SEIZURE; VOMITING; HIV INFECTIONS; MENINGITIS, CRYPTOCOCCAL; MULTIVARIATE ANALYSIS;

ADOLESCENT; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CHINA; HIV INFECTIONS; HUMANS; MENINGITIS, CRYPTOCOCCAL; MULTIVARIATE ANALYSIS; RISK FACTORS;

EID: 84871475292     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-12-376     Document Type: Article

References (33)

1. Park BJ, Wannemuehler KA, Marston BJ, Govender N, Pappas PG, Chiller TM. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS 2009, 23(4):525-530. 10.1097/QAD.0b013e328322ffac, 19182676.
2. Mofenson LM, Brady MT, Danner SP, Dominguez KL, Hazra R, Handelsman E, Havens P, Nesheim S, Read JS, Serchuck L, Van Dyke R. Centers for Disease Control and Prevention; National Institutes of Health; HIV Medicine Association of the Infectious Diseases Society of America; Pediatric Infectious Diseases Society; American Academy of Pediatrics. Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics. MMWR Recomm Rep 2009, 58(RR-11):1-166.
3. Hajjeh RA, Conn LA, Stephens DS, Baughman W, Hamill R, Graviss E, Pappas PG, Thomas C, Reingold A, Rothrock G, Hutwagner LC, Schuchat A, Brandt ME, Pinner RW. Cryptococcosis: population-based multistate active surveillance and risk factors in human immunodeficiency virus-infected persons. Cryptococcal Active Surveillance Group. J Infect Dis. 1999, 179(2):449-454. 10.1086/314606, 9878030.
4. Chen S, Sorrell T, Nimmo G, Speed B, Currie B, Ellis D, Marriott D, Pfeiffer T, Parr D, Byth K. Epidemiology and host- and variety-dependent characteristics of infection due to Cryptococcus neoformans in Australia and New Zealand. Australasian Cryptococcal Study Group. Clin Infect Dis. 2000, 31(2):499-508. 10.1086/313992, 10987712.
5. Gumbo T, Kadzirange G, Mielke J, Gangaidzo IT, Hakim JG. Cryptococcus neoformans meningoencephalitis in African children with AIDS. Pediatr Infect Dis J 2002, 21(1):54-56. 10.1097/00006454-200201000-00012, 11791100.
6. Mirza SA, Phelan M, Rimland D, Graviss E, Hamill R, Brandt ME, Gardner T, Sattah M, de Leon GP, Baughman W, Hajjeh RA. The changing epidemiology of cryptococcosis: an update from population-based active surveillance in 2 large metropolitan areas, 1992-2000. Clin Infect Dis 2003, 36(6):789-794. 10.1086/368091, 12627365.
7. Othman N, Abdullah NA, Wahab ZA. Cryptococcal meningitis in an immunocompetent child: a case report and literature review. Southeast Asian J Trop Med Public Health 2004, 35(4):930-934.
8. Huang KY, Huang YC, Hung IJ, Lin TY. Cryptococcosis in nonhuman immunodeficiency virus-infected children. Pediatr Neurol 2010, 42(4):267-270. 10.1016/j.pediatrneurol.2009.10.015, 20304330.
9. Joshi NS, Fisher BT, Prasad PA, Zaoutis TE. Epidemiology of cryptococcal infection in hospitalized children. Pediatr Infect Dis J 2010, 29(12):e91-e95. 10.1097/INF.0b013e3181fbc83d, 20935590.
10. Ndiaye M, Diagne NR, Seck LB, Sow AD, Sène MS, Diop AG, Sow HD, Ndiaye MM. Cryptococcal meningitis in children: description of 3 cases. Med Trop (Mars). 2011, 71(2):176-178.
11. Chen YY, Lai CH. Nationwide population-based epidemiologic study of cryptococcal meningitis in Taiwan. Neuroepidemiology 2011, 36(2):79-84. 10.1159/000323390, 21282964.
12. Yuanjie Z, Jianghan C, Nan X, Xiaojun W, Hai W, Wanqing L, Julin G. Cryptococcal meningitis in immunocompetent children. Mycoses 2012, 55(2):168-171.
13. Xu BP, Shen KL, Zhao SY. Disseminated cryptococcosis in 28 previously healthy children. Pediatr Respir Rev. 2012, 13(Supp 1):S83.
14. Mitchell TG, Perfect JR. Cryptococcosis in the era of AIDS-100 years after the discovery of Cryptococcus neoformans. Clin Microbiol Rev 1995, 8(4):515-548. 172874, 8665468.
15. Chayakulkeeree M, Perfect JR. Cryptococcosis. Infect Dis Clin North Am 2006, 20(3):507-544. 10.1016/j.idc.2006.07.001, 16984867.
16. Litvintseva AP, Thakur R, Reller LB, Mitchell TG. Prevalence of clinical isolates of Cryptococcus gattii serotype C among patients with AIDS in sub-Saharan Africa. Eukaryot Cell 2005, 192(5):888-892.
17. Steele KT, Thakur R, Nthobatsang R, Steenhoff AP, Bisson GP. In-hospital mortality of HIV-infected cryptococcal meningitis patients with C. gattii, C. neoformans infection in Gaborone, Botswana. Med Mycol 2010, 48(8):1112-1115. 10.3109/13693781003774689, 20438294.
18. Chen J, Varma A, Diaz MR, Litvintseva AP, Wollenberg KK, Kwon-Chung KJ. Cryptococcus neoformans strains and infection in apparently immunocompetent patients, China. Emerg Infect Dis 2008, 14(5):755-762. 10.3201/eid1405.071312, 2600263, 18439357.
19. Idnurm A, Bahn YS, Nielsen K, Lin X, Fraser JA, Heitman J. Deciphering the model pathogenic fungus Cryptococcus neoformans. Nat Rev Microbiol 2005, 3(10):753-764. 10.1038/nrmicro1245, 16132036.
20. MacDougall L, Kidd SE, Galanis E, Mak S, Leslie MJ, Cieslak PR, Kronstad JW, Morshed MG, Bartlett KH. Spread of Cryptococcus gattii in British Columbia, Canada, and detection in the Pacific Northwest, USA. Emerg Infect Dis 2007, 13(1):42-50. 10.3201/eid1301.060827, 2725832, 17370514.
21. Viviani MA, Cogliati M, Esposto MC, Lemmer K, Tintelnot K, Colom Valiente MF, Swinne D, Velegraki A, Velho R, European Confederation of Medical Mycology (ECMM) Cryptococcosis Working Group Molecular analysis of 311 Cryptococcus neoformans isolates from a 30-month ECMM survey of cryptococcosis in Europe. FEMS Yeast Res 2006, 6(4):614-619. 10.1111/j.1567-1364.2006.00081.x, 16696657, European Confederation of Medical Mycology (ECMM) Cryptococcosis Working Group.
22. Okamoto K, Hatakeyama S, Itoyama S, Nukui Y, Yoshino Y, Kitazawa T, Yotsuyanagi H, Ikeda R, Sugita T, Koike K. Cryptococcus gattii genotype VGIIa infection in man, Japan, 2007. Emerg Infect Dis 2010, 16(7):1155-1157. 10.3201/eid1607.100106, 3321916, 20587194.
23. Shih CC, Chen YC, Chang SC, Luh KT, Hsieh WC. Cryptococcal meningitis in non-HIV-infected patients. Q J Med 2000, 93(4):245-251.
24. Capoor MR, Nair D, Deb M, Gupta B, Aggarwal P. Clinical and mycological profile of cryptococcosis in a tertiary care hospital. Indian J Med Microbiol 2007, 25(4):401-404. 10.4103/0255-0857.37349, 18087095.
25. Chau TT, Mai NH, Phu NH, Nghia HD, Chuong LV, Sinh DX, Duong VA, Diep PT, Campbell JI, Baker S, Hien TT, Lalloo DG, Farrar JJ, Day JN. A prospective descriptive study of cryptococcal meningitis in HIV uninfected patients in Vietnam - high prevalence of Cryptococcus neoformans var grubii in the absence of underlying disease. BMC Infect Dis 2010, 10:199. 10.1186/1471-2334-10-199, 2910700, 20618932.
26. Pappas PG, Perfect JR, Cloud GA, Larsen RA, Pankey GA, Lancaster DJ, Henderson H, Kauffman CA, Haas DW, Saccente M, Hamill RJ, Holloway MS, Warren RM, Dismukes WE. Cryptococcosis in Human Immunodeficiency Virus-Negative Patients in the Era of Effective Azole Therapy. Clin Infect Dis 2001, 33(5):690-699. 10.1086/322597, 11477526.
27. Julin G, Wang H, Liao W, Pan W. Analysis of clinical and immunologic parameters in patients with cryptococcal meningitis[in Chinese]. J Clin Dermatol. 2003, 23(2):72-73.
28. Netea MG, Brouwer AE, Hoogendoorn EH. Two patients with cryptococcal mentingtis and idiopathic CD4 lymphopenia: defective cytokine production and reversal by recombinant interferon-gamma theraphy. Clin Infect Dis 2004, 39(9):e83-e87. 10.1086/425121, 15494899.
29. Gonzalez CE, Shetty D, Lewis LL, Mueller BU, Pizzo PA, Walsh TJ. Cryptococcosis in human immunodeficiency virus-infected children. Pediatr Infect Dis J 1996, 15:796-800. 10.1097/00006454-199609000-00012, 8878224.
30. Meiring ST, Quan VC, Cohen C, Dawood H, Karstaedt AS, McCarthy KM, Whitelaw AC, Govender NP, for the Group for Enteric, Respiratory and Meningeal disease Surveillance in South Africa (GERMS-SA) A comparison of paediatric- and adult-onset cryptococcosis detected through population-based surveillance in South Africa, 2005-2007. AIDS 2012, 26. for the Group for Enteric, Respiratory and Meningeal disease Surveillance in South Africa (GERMS-SA).
31. Lindsley MD, Mekha N, Baggett HC, Surinthong Y, Autthateinchai R, Sawatwong P, Harris JR, Park BJ, Chiller T, Balajee SA, Poonwan N. Evaluation of a newly developed lateral flow immunoassay for the diagnosis of cryptococcosis. Clin Infect Dis 2011, 53(4):321-5. 10.1093/cid/cir379, 3148258, 21810743.
32. Denning DW, Hope WW. Therapy for fungal diseases: opportunities and priorities. Trends Microbiol 2010, 18(5):195-204. 10.1016/j.tim.2010.02.004, 20207544.
33. Roy M, Chiller T. Preventing deaths from cryptococcal meningitis: from bench to bedside. Expert Rev Anti Infect Ther 2011, 9(9):715-7. 10.1586/eri.11.86, 21905781.